Status: current, Defined. Date: 31-Jan 2021. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4508491000168118 | Memantine (LAPL) (memantine hydrochloride 20 mg) tablet (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4508501000168113 | Memantine (LAPL) 20 mg tablet | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Memantine (LAPL) 20 mg tablet | Is a | Memantine (LAPL) | true | Inferred relationship | Some | ||
| Memantine (LAPL) 20 mg tablet | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Memantine (LAPL) 20 mg tablet | Is a | memantine hydrochloride 20 mg tablet | true | Inferred relationship | Some | ||
| Memantine (LAPL) 20 mg tablet | has manufactured dose form | tablet | true | Inferred relationship | Some | ||
| Memantine (LAPL) 20 mg tablet | has Australian BoSS | memantine hydrochloride | true | Inferred relationship | Some | 1599964719 | |
| Memantine (LAPL) 20 mg tablet | has intended active ingredient | memantine | true | Inferred relationship | Some | 1599964719 | |
| Memantine (LAPL) 20 mg tablet | has unit of use | tablet | true | Inferred relationship | Some | 2042172924 |
Reference Sets
Trade product unit of use reference set
FHIR